The merging of life science and computer science, our deepening understanding to engineer and manipulate biology, and fundamentally new tools to build and move things, are the first glimpses into a new era of frontier technologies. The value they create goes beyond the cap table, saving lives, and protecting the planet. We fund and incubate them at the earliest stages — providing support to derisk and scale.
We believe the next generation of great deeptech companies are built by diverse, fearless change agents. Today, over half of our investment portfolio consists of all-women or minority founders.
Accelerating cure to patients
We are at a hinge moment in biolgy, where we are seeing profound changes in drug discovery and development powered by the union of technology and bio. At Coho we call this generative therapeutics. After decades of manual methods, we can now reimagine the drug discovery and design process by using AI and machine learning-powered computational models.
Re-engineer the health stack
Increasingly, drugs are not the only way to make people healthier. For many conditions, software may be our best way to impact human physiology. Digital health have the potential to not only make you better, but themselves get better and better over time. Founders are re-engineering the way we access, deliver, and pay for care.
Applied AI to transform industries
By the next century, we believe in a world that's far more efficient, creative, and productive. So we are funding AI-enabled technologies that change the way we build things and spend time. From manufacturing and transportation, to design and imagine, cutting-edge AI companies are on it
One More Thing
×
Custom Works
×
New Projects?
If you need custom work, if you want to collaborate with me on social networks or propose some new project – choose your way to contact me: